Bluejay Diagnostics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bluejay Diagnostics, Inc. (Nasdaq: BJDX) on October 2, 2023, regarding events that occurred on September 26, 2023. The filing addresses significant changes in the Company's executive leadership, specifically within the finance function.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Departure of CFO: Kenneth R. Fisher ceased serving as Chief Financial Officer and employee effective September 26, 2023. He may be entitled to severance under his employment agreement.
- Appointment of Interim CFO: The Board appointed Frances Scally as Interim Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer, effective immediately.
- Engagement Structure: Ms. Scally is engaged through a scope of work and master services agreement with DLA LLC. The Company will pay DLA on an hourly basis for her services.
- Additional Advisory Role: Scott Levy will serve as a special advisor to the CEO, complementing Ms. Scally's role, also billed on an hourly basis through DLA LLC.
Outlook, Risks, and Management Commentary
The filing does not contain forward-looking guidance, risk factors, or management commentary regarding the Company's strategic outlook. The primary focus is the transition of financial leadership. Ms. Scally brings significant experience, having previously served as CFO for SeqLL Inc. and in senior accounting roles at Aceto Holdings and Veeco Instruments.
Key Facts for Investor Verification
- Verify the specific terms of the severance agreement for the departing CFO, Kenneth R. Fisher.
- Confirm the hourly rates and total estimated costs associated with the engagement of DLA LLC for the interim CFO and special advisor.
- Monitor the timeline for the appointment of a permanent Chief Financial Officer.
- Review the Company's next periodic report (10-Q or 10-K) for the impact of this leadership change on financial reporting and internal controls.